---
title: "Sensus Healthcare, Inc. (SRTS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SRTS.US.md"
symbol: "SRTS.US"
name: "Sensus Healthcare, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T08:34:33.599Z"
locales:
  - [en](https://longbridge.com/en/quote/SRTS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SRTS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SRTS.US.md)
---

# Sensus Healthcare, Inc. (SRTS.US)

## Company Overview

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [ensushealthcare.com](https://ensushealthcare.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: D (0.64)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 142 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -42.94% |  |
| Net Profit YoY | -531.59% |  |
| P/B Ratio | 1.21 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 55147897.65 |  |
| Revenue | 22532000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -15.77% | E |
| Profit Margin | -34.50% | E |
| Gross Margin | 29.20% | C |
| Revenue YoY | -42.94% | E |
| Net Profit YoY | -531.59% | E |
| Total Assets YoY | -14.39% | E |
| Net Assets YoY | -14.13% | E |
| Cash Flow Margin | 0.00% | D |
| OCF YoY | -42.94% | E |
| Turnover | 0.40 | C |
| Gearing Ratio | 11.65% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Sensus Healthcare, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-42.94%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-531.59%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.21",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "55147897.65",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "22532000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-15.77%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-34.50%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "29.20%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-42.94%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-531.59%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-14.39%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-14.13%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-42.94%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.40",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "11.65%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -7.09 | 133/183 | 46.57 | 43.46 | 42.00 |
| PB | 1.21 | 33/183 | 1.51 | 1.35 | 1.07 |
| PS (TTM) | 2.45 | 58/183 | 2.37 | 1.97 | 1.48 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-18T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 75% |
| Overweight | 1 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 3.35 |
| Highest Target | 8.00 |
| Lowest Target | 6.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SRTS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SRTS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SRTS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SRTS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**